CellSeed
7776
Def Consulting
4833
Leoclan
7681
Timee
215A
Bank of Innovation
4393
(FY)Feb 20, 2024 | (FY)Feb 20, 2023 | |
---|---|---|
Total revenue | -14.74%1.63B | 1.91B |
Cost of revenue | -17.02%1.06B | 1.28B |
Gross profit | -10.13%567.43M | 631.37M |
Operating expense | 4.61%664.67M | 635.37M |
Operating profit | -2,336.00%-97.25M | -3.99M |
Net non-operating interest income (expenses) | -59.70%-3.93M | -2.46M |
Non-operating interest expense | 59.70%3.93M | --2.46M |
Net investment income | 355.30%4.51M | -1.77M |
Gain(Loss) on financial instruments designated as cash flow hedges | ||
Gain(Loss) on derecognition of available-for-sale financial assets | ||
Income from associates and other participating interests | ||
Special income (charges) | -33.01%7.56M | 11.29M |
Less:Other special charges | 27.45%-8.19M | ---11.29M |
Less:Write off | --627K | --0 |
Other non-operating income (expenses) | 314.43%14.85M | 3.58M |
Income before tax | -1,216.24%-74.25M | 6.65M |
Income tax | -914.52%-24.52M | 3.01M |
Net income | -1,465.60%-49.74M | 3.64M |
Net income continuous operations | -1,465.60%-49.74M | --3.64M |
Noncontrolling interests | ||
Net income attributable to the company | -1,465.94%-49.73M | 3.64M |
Preferred stock dividends | ||
Other under preferred stock dividend | 0 | 0 |
Net income attributable to common stockholders | -1,465.94%-49.73M | 3.64M |
Gross dividend payment | ||
Basic earnings per share | -1,465.94%-248.67 | 18.205 |
Diluted earnings per share | -1,465.94%-248.67 | 18.205 |
Dividend per share | ||
Currency Unit | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP |